Royce & Associates LP Tandem Diabetes Care Inc Transaction History

Royce & Associates LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$93.51 - $129.4 $7.32 Million - $10.1 Million	-78,286 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$77.0 - $100.19 $762,300 - $991,881	9,900 Added 14.48%	78,286 $7.63 Million
Q1 2021 May 10, 2021	BUY	$81.28 - $104.34 $105,664 - $135,642	1,300 Added 1.94%	68,386 $6.04 Million
Q4 2020 Feb 08, 2021	BUY	$86.4 - $121.75 $2.75 Million - $3.87 Million	31,800 Added 90.12%	67,086 $6.42 Million
Q3 2020 Nov 12, 2020	BUY	$95.43 - $116.09 $1.12 Million - $1.36 Million	11,700 Added 49.61%	35,286 $4.01 Million
Q2 2020 Aug 07, 2020	SELL	$60.05 - $98.92 $840,700 - $1.38 Million	-14,000 Reduced 37.25%	23,586 $2.33 Million
Q1 2020 May 12, 2020	SELL	$47.37 - $90.04 $1.4 Million - $2.66 Million	-29,500 Reduced 43.97%	37,586 $2.42 Million
Q4 2019 Feb 06, 2020	BUY	$53.13 - $71.19 $881,214 - $1.18 Million	16,586 Added 32.84%	67,086 $4 Million
Q3 2019 Nov 13, 2019	BUY	$57.11 - $73.3 $2.88 Million - $3.7 Million	50,500 New	50,500 $2.98 Million

361

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.